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Abstract
Background: The effect of the recent world recession on population health has featured heavily in recent
international meetings. Maternal health is a particular concern given that many countries were already falling short
of their MDG targets for 2015.
Methods: We utilise 20
th century time series data from 14 high and middle income countries to investigate
associations between previous economic recession and boom periods on maternal and infant outcomes (1936 to
2005). A first difference logarithmic model is used to investigate the association between short run fluctuations in
GDP per capita (individual incomes) and changes in health outcomes. Separate models are estimated for four
separate time periods.
Results: The results suggest a modest but significant association between maternal and infant mortality and
economic growth for early periods (1936 to 1965) but not more recent periods. Individual country data display
markedly different patterns of response to economic changes. Japan and Canada were vulnerable to economic
shocks in the post war period. In contrast, mortality rates in countries such as the UK and Italy and particularly the
US appear little affected by economic fluctuations.
Conclusions: The data presented suggest that recessions do have a negative association with maternal and infant
outcomes particularly in earlier stages of a country’s development although the effects vary widely across different
systems. Almost all of the 20 least wealthy countries have suffered a reduction of 10% or more in GDP per capita
in at least one of the last five decades. The challenge for today’s policy makers is the design and implementation
of mechanisms that protect vulnerable populations from the effects of fluctuating national income.
Background
What effect is the current worldwide recession likely to
have on the health of populations, particularly those in
the least wealthy countries? This key question has fea-
tured strongly in international meetings such as the G8,
and as a focus of several initiatives, including the High
Level Taskforce for Innovative Financing [1]. Prior to
the present economic slump there was already consider-
able concern that many countries were failing to have a
substantial impact on basic health outcomes [2]. In par-
ticular, many of the least wealthy countries are essen-
tially off-track to achieve the 2015 targets for child and
maternal health (Millennium Development Goals 4 &5)
set by the international community in 2000 and to be
reviewed intensively this year. A core policy question is
what governments in aid-receiving and donor-countries
can do to mitigate the effect of the current recession.
Will any mortality gains be reversed, for example, or
will the opportunity cease to protect vulnerable groups
and so accelerate progress? This paper explores such
questions through examination of an historic dataset
assembled on maternal and infant mortality for selected
rich and middle income countries spanning most of the
twentieth century and a period of both recession and
growth.
Health outcomes and incomes
The study used GDP per capita as a general descriptor
for the state of the economy. Recession is generally
defined as two quarters of negative economic growth.
The impacts are clearly felt beyond a change in income
in particular on levels of employment, poverty and
unequal effects on different socio-economic groups.
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influences but provides a useful summary variable for
the general health of the economy that is available uni-
versally and consistently available for most countries
unlike, for example, unemployment and poverty rates
where local definitions and conventions vary widely.
The link between individual income and health out-
comes is well established at an individual level. At a
national level, whilst it is self evidently true that poorer
countries generally have inferior health status, the link
between changes in income and health outcomes is less
clear cut. There are a number of routes through which
recession may impact on health outcomes (Figure 1).
Household income is directly affected, which in turn
affects a household’s ability to cover out of pocket costs
of services (1). In systems that are free at point of deliv-
ery these are mainly ‘demand-side’ costs: transport, time
taken away from work. The potential effect is larger in
systems where a user must also contribute to the cost of
service through a user charge.
In addition, spending on health care services is deter-
mined by the State’s ability to raise funds through taxa-
tion, social insurance or other means. This in turn
affects the ability of a national government to properly
finance basic services (2). A recent study of progress
towards the Millennium Development Goals (MDGS)
found that the direct influence of GDP on health was
positive but relatively modest [3]. At the same time the
effect of increased human resources made possible by
greater spending was strongly associated with progress
towards the MDGs. The combined influence of changes
in income through the effect on households and public
spending is therefore substantial.
Recession also impacts on the State’s ability to fully
finance transfer payments such as pension and unem-
ployment benefits, which in turn affect health improving
expenditures (3). A sharp decline in the real value of
state pensions in Russia during the late 1990 s, for
example, was associated with a reduction in the use of
health services, protein consumption and life expectancy
amongst pensioners [4].
T h en e g a t i v ee f f e c to ns p e n d i n gm a yb eo f f s e ts o m e -
what if a government chooses to protect basic health
services at the expense of other commitments. It is
thought, for example, that in Cuba preferential access
given to services for women and children may have
helped to protect basic health outcomes from the worst
effects of the US embargo [5]. Assistance from donors,
which finances a substantial part of the health sector in
many developing countries, could also ease the impact,
although worldwide recession might distort these flows.
A Russian study suggests that health is also affected
positively or negatively by consumption of other goods
and behaviours (4). In the United States, data suggest
that recessions tend to lead to reductions in fertility [6].
This study indicates that this effect is asymmetrical as
increasing unemployment makes poorer families more
cautious about having children. Since these households
consistently have higher maternal and child mortality
than the rest of the population, there was an associated
improvement in average health outcomes. Similarly, a
study in post-war Japan found that deaths commonly
associated with poor lifestyles and the consumption of
‘health bads’ such as poor diet or tobacco use are pro-
cyclical - in other words, they tend to increase when the
economy improves [7]. Similar evidence was reported
for the United States with smoking and obesity related
disease in particular increasing when the economy
strengthens [8].
The relationship between health and income is thus
not uni-directional nor consistent across time or set-
tings. Better health can drive improvements in liveli-
hoods and contribute to increased national wealth [6].
There is evidence, for example, that improvements in
l i f ee x p e c t a n c yh a v eap o s i t i v ee f f e c to nG D Pg r o w t h
rates, and that improved maternal and infant health
improves the economic position of households [9,10].
Conversely, differences in growth rates between Africa
and Asia have at least partly been attributed to differ-
ences in underlying health outcomes [11]. There is well
established evidence that the relationship between
income and health outcomes is more important for
countries at an earlier stage of development [12]. This
suggests that the impact of economic shocks will also
change (weaken) as the economy grows.
One of the problems with assessing the effect of reces-
sion is assembling a sufficient time series of data on
health outcomes. A recent study took advantage of the
substantial dataset provided by the Demographic and
Health Surveys, a standard survey methodology examin-
ing reproductive and child health and now applied in
more than 75 countries, to examine the association
Figure 1 Health and wealth: simplified causal relationships.
Various routes through which recession may impact on health
outcomes. The numbers in this figure link to textual references.
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59 countries. The study found a substantial negative
effect of per capita income on infant mortality [13]. In
this paper we use a time series assembled from records
dating back to the early 20
th century in order to exam-
ine the effect of income on infant and maternal
mortality.
Methods
The analysis focuses on 14 high and middle income
countries: high income countries were United Kingdom,
United States, Japan, Italy, Canada, France, and Ger-
many; low/middle income countries were Argentina,
Brazil, Malaysia, Mexico, Nicaragua, Russia and Thai-
land. The time series for each country was assembled
from a variety of historical sources. For high income
countries data were obtained from as early as 1915, but
records from this time until the mid-1930 s are patchy
and inconsistent, resulting in implausible estimates (as
seen in Figure 2 below). The series for these high
income countries as a whole appears to become more
consistent from 1936 and this year is, therefore, used as
the starting point for the analysis reported in this paper.
Regressions were undertaken using data for the earlier
period but, not surprisingly given the quality of the data,
there were no statistically significant associations. For
most of the low/middle income countries, data are not
available until the 1950 s or later. Per capita income
(Gross Domestic Product) was obtained for the same
period using the Maddison database [14]. The data set
permits an examination of the long run effects of GDP
fluctuations on maternal and infant mortality. Data were
extracted from various sources e.g Demographic Year
Books, and were also received directly from contact with
the National Statistics Offices (see acknowledgements).
Estimates of the maternal mortality ratio - the most
commonly used measure (maternal deaths per 100,000
live births) used here only includes direct obstetric
causes of death since this enables the longest consistent
time-series to be viewed across the selected countries.
Indirect causes were not included into most national
routine statistics of maternal deaths until after the mid-
1960 s.
The substantial negative association between long run
GDP per capita and mortality is borne out both by gra-
phical representation (Figure 2) and simple regressions
of outcomes (maternal mortality ratio (MMR) and infant
mortality rate (IMR)) on GDP per capita (log values)
(Table 1). The association with income appears to vary
over the years, with the strongest correlation in the
1966 to 1980 period for MMR and 1981 and later for
IMR.
The rich country group appears to divide into two dis-
tinct sub-groups with regard to maternal mortality. In
both Italy and Japan lower maternal mortality is
reported from the beginning of the time series, yet their
infant mortality remains comparable to other countries.
Levels of maternal mortality in the UK, United States
and Canada are reported as substantially higher in the
1 9 2 0sa n de a r l y1 9 3 0sa n di ti so n l yf r o mt h el a t e
1930 s and mid-1940 s that levels fall substantially to
those at or below those reported in Japan and Italy. The
dramatic decline found here in the UK, USA and
Canada is consistent with other published series, such as
the work of Loudon [15].
Long run time trends mean that any association
between the variables using untransformed data will
tend to be dominated by the trend itself rather than
explaining the effect of deviations from the trend pro-
duced by recession or temporary booms. Our paper
thus follows other studies of the effect of the macro-
economy by transforming outcomes and GDP in order
to focus on short term fluctuations [7,13]. A first differ-
ence logarithmic transformation regresses the change in
mortality outcomes on changes in GDP per capita (con-
stant prices). Fertility is strongly associated with mater-
nal and infant deaths and so is an important potential
confounder. The crude birth rate is added to proxy this
effect (the total fertility rate is not available for all
Figure 2 Long run trends in maternal mortality.G r a p h i c a l
representation of substantial negative association between long run
GDP per capita and mortality.
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Page 3 of 9observations in the data set). Lagged (logged) values of
the mortality and income variable are also included. The
format is specified as follows:
lnH lnH lnGDPPC lnGDPPC
lnGDPPC
ct ct u ct ct u
ct u







22 24 HC B R ct u ct u −− + b
Where Hct is the health status variable of interest at
time t and country c, GDPPCct (time t, country c) is
GDP per capita in real (2000) US dollars, CBR is the
crude birth rate and u is the lag. A lag of five years is
used for all models. The reason is that mortality data
are mostly available at five year intervals. Whilst it is
possible to impute values between these years, there is
no possibility of picking up genuine fluctuations in mor-
tality on a more regular basis. The use of a fixed lag is
less restrictive than it seems: in the context of this
model, a lag means that the cumulative five year change
in GDP is expected to have a cumulative five year asso-
ciation with health outcomes.
We investigate the dataset in two stages. First, both
fixed and random effects panel regression were used to
explore the effect of changing per capita income on
maternal, infant and neonatal mortality. A Hausman
test, used to test the consistency of random versus fixed
effects, was statistically significant (P < 0.01), implying
that random effects are inconsistent and a fixed model
should be used for both the upper and middle/low
income country groups. Separate estimation was carried
out for the (now) upper income countries and low/mid-
dle income countries. The dataset for the upper income
countries was divided into fifteen year time periods:
1936 to 1950, 1951 to 1965, 1966 to 1980 and 1981 to
2005. The data for low/middle income countries is not
divided by periods because of the small number of
observations available for the earlier time periods. One
of the potential problems with this specification is
simultaneity bias if gdp per capita both determines
maternal and infant outcomes and is affected by them.
The use of change variables should minimise this risk.
An instrumental variable (xtivreg in Stata) method that
mitigates simultaneity leading to inconsistent estimates
was also estimated. A time trend and total fertility rate
were used to instrument the change in GDP variable. A
Hausman test was also used to compare specifications
and test for inconsistency. The tested was rejected (p >
0.5) for both low/middle and upper income groups sug-
gesting no evidence of simultaneity.
A second stage of modelling was to focus on each
country individually and the differences in association
between per capita income and health during the four
post-war time periods. Statistical tests - Durbin Watson
(DW) and Breusch-Pagan - indicated that ordinary least
squares regression is inefficient as a result of heterosce-
dastic and autocorrelated (lag 1) errors. Durbin Watson
statistics all indicated positive serial correlation with the
statistic below the lower bound of significance (Statistics
as follows: United Kingdom 0.86, United States 0.26,
Japan 0.86, Italy 1.14, Canada 0.98). A generalised least
squares model with robust standard errors was therefore
used (Prais-Winsten and Cochrane-Orcutt error correc-
tion regression, specified as ‘Prais’ in Stata v10.1). Post-
estimated DW statistics suggested that the correction
had successfully eliminated serial correlation from the
estimation for Canada, Italy and Japan and reduced for
United States and UK (the statistic was in the zone of
indeterminacy).
Results
A negative association (significant at 5% level) between
changes in income and outcomes was found for both
maternal and infant mortality (Table 2). Estimation
across the four periods suggests that the absolute effect
of short run fluctuations in per capita income declines
over time. A significant negative association between
changes in income and both maternal and infant mor-
tality is indicated in the first two periods (1936 to 1950,
1951 to 1965). The absolute impact is similar since
whilst the coefficient is larger in the second period the
mean value is lower. In both periods a 10% reduction in
income implies an increase in the MMR of just over six
deaths per 100,000 live births. In subsequent periods
Table 1 Association between health outcomes and GDP per capita
1936 to 1950 1951 to 1965 1966 to 1980 1981 and later All years All years
High income economies Low/Middle income
Coefficient t-stat Coefficient t-stat Coefficient t-stat Coefficient t-stat Coefficient t-stat Coefficient t-stat
MATERNAL MORTALITY RATIO
ln_gdp - 0.739 -3.09 - 1.205 -8.77 - 3.036 -17.01 - 1.095 -5.86 - 2.287 -48.5 - 1.910 - 42.70
Constant 11.707 5.78 14.913 12.27 31.588 18.8 12.602 6.85 24.552 57.11 20.130 - 54.80
INFANT MORTALITY RATE
ln_gdp - 0.284 -3.16 - 1.037 -32.24 - 1.604 -27.02 - 1.895 -30.45 - 1.575 -105.26 - 1.099 -29.05
Constant 6.613 8.75 12.686 44.67 17.929 32.1 20.509 33.51 17.495 129.54 12.803 41.92
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association is detected. Likewise, for infant mortality in
the first two periods a 10% reduction in income is asso-
ciated with a statistically significant (1% level) increase
in IMR of around 3/1000 live births. For neonatal deaths
a significant negative effect is only found in period two
(1951 to 1965), although the paucity of data for the first
period reduces the statistical power of the regression.
Lack of data precludes a separation of results by per-
iod for the low/middle income country group. Pooled
estimations for maternal and infant outcomes suggest a
significant negative effect of income (Table 2). A 10%
reduction in real GDP per capita is associated with an
increase in the MMR of 16 (8.5%) and IMR of 1.4 (2%);
equivalent to an additional 13,500 infant and 1,500
maternal deaths across the seven low/middle income
countries included in the study.
Whilst the associations explored in this pooled analy-
sis are statistically significant, the magnitude of the
effects is relatively modest. The data series (Figure 1)
suggest that patterns of decline in mortality, and mater-
nal mortality in particular, differ between countries.
This is indeed confirmed in the individual country
regressions. The data imply a substantial but varying
association with MMR (Figure 3 & 4). A number of pat-
terns can be discerned. Firstly, for two countries, Japan
and Canada, substantial and statistically significant
increases in maternal mortality coincide with GDP
decline in the 1950 to 1966 period. This relationship
was found to continue from 1966 to 1980, although it
only remains significant for Japan. Interestingly these
two countries exhibited similar trends and levels of
maternal mortality by the 1950 s, but for the earlier per-
iods had rather different trajectories and indeed
Table 2 Associations between health outcomes and changes in GDP per capita
Upper income countries Middle/low income
countries All years
1936 to 1950 1951 to 1965 1966 to 1980 1981 to 2005 All years
VARIABLE MEANS
MMR 257 83 25 7 70 181
IMR 71 35 18 7 29 56
NNMR 30 19 12 4 13
GDP per cap 5,089 7,347 12,412 19,009 12,210 3,957
MATERNAL MORTALITY RATIO
Coefficient t-stat Coefficient t-stat Coefficient t-stat Coefficient t-stat Coefficient t-stat Coefficient t-stat
Change GDP - 0.22 - 2.95 - 0.73 - 2.30 - 0.93 - 1.56 - 0.06 - 0.10 - 0.22 - 2.11 - 0.77 -4.93
GDP-5 - 0.70 - 5.21 - 0.46 - 3.24 - 1.85 - 5.75 0.14 0.48 - 0.62 - 9.05 - 0.26 -1.99
MMR-5 0.21 2.53 - 0.39 - 8.65 - 0.80 - 6.92 - 0.70 - 8.24 - 0.25 - 11.39 - 0.22 -3.48
CBR-5 0.37 1.58 0.19 1.02 1.14 4.69 1.12 2.85 - 0.25 - 2.41 0.14 2.63
Constant 3.15 2.35 4.94 2.60 16.32 4.80 - 3.00 - 0.83 7.01 7.95 2.49 1.79
Observations 75 75 85 164 399 212
Groups 5 5 6 7 7 7
F statistic 29.02 27.38 16.06 24.93 35.45 10.91
Prob > F <0.001 <0.001 <0.001 <0.01 <0.01 p < 0.01
INFANT MORTALITY RATE
Change GDP - 0.36 - 4.21 - 0.64 - 5.62 - 0.01 - 0.03 - 0.05 - 0.31 - 0.41 - 11.04 - 0.20 -2.43
GDP-5 - 0.57 - 3.93 - 0.53 - 6.97 - 0.35 - 1.96 - 0.99 - 6.09 - 0.26 - 6.56 - 0.15 -3.65
IMR-5 - 0.56 - 3.79 - 0.57 - 9.94 - 0.38 - 3.00 - 0.51 - 8.39 - 0.18 - 6.62 - 0.11 -3.68
CBR-5 0.85 3.60 0.05 0.71 0.43 7.87 - 0.46 - 5.32 0.06 1.67 - 0.04 -0.85
Constant 4.53 2.91 6.48 6.68 2.96 1.41 11.72 6.38 2.63 5.72 1.63 3.37
Observations 104 105 105 182 496 294
Groups 7 7 7 7 7 7
F statistic 11.39 39.35 20.92 44.76 33.39 26.56
Prob > F p < 0.01 p < 0.01 p < 0.01 p < 0.01 p < 0.01 p < 0.01
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Figure 3 Changes in MMR associated with 10% reduction in (real) GDP per capita.
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to the end of the observed period - 1980. The second
type of pattern is one of inconsistency and is demon-
strated by the United Kingdom and Italy. In two periods
the association is pro-cyclical, thus a decline in income
leads to a reduction in maternal deaths (significant only
for the 1966 to 1980 period). Taking all periods
together, the relationship is not statistically significant.
The third and final pattern is one characterised by a
consistent lack of effect on maternal mortality of fluctu-
ating income, as seen in the United States series. There
are several possible explanations for this apparent insu-
lation against economic shocks. One is that the coun-
try’s economy has reached the stage whereby
prioritisation of maternal health care is not, at the mar-
gin, affected by changes in income. A further possible
explanation is the adjustments mentioned by Dehejia et
al [16], whereby families reduce births during periods of
recession. This impacts disproportionately on poorer
women, who also tend to have inferior maternal health
outcomes and, as a consequence, the overall level of
maternal mortality falls. Interestingly, the picture for
infant mortality is somewhat different from all three
patterns regarding maternal mortality. In the US, for
example, a substantial and statistically significant effect
on IMR was associated with falls in income.
Discussion
There is evidence to suggest that income is becoming
less important as a determinant of mortality outcomes
today than it was in the past [17]. Technological gains
that historically took decades to achieve and to scale-up
in now rich countries are potentially available at much
lower cost to countries and at an earlier stage of devel-
opment. This effect is borne out by the work of Kenny
and others that suggest that while infant mortality has
consistently fallen worldwide since 1900, the link to
income growth is weakening [17]. Better average health
outcomes would thus appear to be achievable in the
modern era at lower average income levels. Yet the
experience of the 14 countries in the sample in this
paper suggests overall trend improvements in income
only tell part of the story. Fluctuations from the trend
as the economy goes through recession or growth is
also associated with basic health outcomes like mortal-
ity. This was true for the high income countries in our
series just before and soon after the Second World War
and also appears to hold for the low/middle income
countries in the 1960 s and 1970 s.
Furthermore, there seem to be differences in the
experiences of the countries in the group. Since the Sec-
ond World War, economic cycles appear to have a sub-
stantially greater association with maternal mortality in
Japan, Italy and Canada than in the United States or the
United Kingdom. The reasons for these differences are
not entirely clear. In the United Kingdom, for example,
it could be conjectured that the introduction of the
National Health Service ensured financial access in good
times and bad, and for all types of health problems. Yet
similar risk pooling was not and still is not available in
the United States for all conditions, despite the intro-
duction of Medicaid and Medicare in the 1960 s. The
US system does, however, provide free Emergency
Room (Emergency Medical Treatment and Active Labor
Act, 1986) care which will include emergency complica-
tions during acute pregnancy and childbirth. There is
also some evidence that families in the United States
and in other developed economies make adjustments to
their expectations about family size in response to eco-
nomic cycles. This ‘feedback’ may, in turn, help to mini-
mise adverse effect on health outcomes, particularly
amongst the poorest groups. There is good historical
and contemporary evidence that the burden of maternal
mortality within developed and developing countries is
borne disproportionately by the poor [17-19]. The
national data used in our analysis necessarily masks dif-
ferential effects of recession on marginalised groups but
it is reasonable to expect that much of this effect would
be on the poorest groups for which there would be
much larger changes in mortality. This key issue has
major implications for equity goals, and would benefit
from further investigation at a country level, including
changes in uptake of care in the face of recession.
Substantial reductions in GDP per capita in richer
countries are rare. Recession is generally defined as nega-
tive growth for two or more consecutive quarters, and
negative growth of more than 5% is unusual [20]. Yet in
the developing world negative growth remains common.
High population growth means than even zero or modest
positive overall growth still leads to declining per capita
incomes. According to World Bank data, 18 of the 20
poorest countries suffered a 10% reduction in GDP per
capita, eight suffered a 20% reduction, and six a 30% (or
more) reduction in at least one of the last five decades
(based on 2007 GDP per capita and excludes Zimbabwe,
North Korea and Palestine due to lack of data). The mod-
els presented in this paper suggest that such reductions
could have a substantial effect on maternal and infant
mortality in these countries. The likelihood of such
effects becoming a reality is supported by other studies
particularly that of Baird and colleagues [13] for infant
outcomes, and highlighted in recent international docu-
ments [1]. Studies in Thailand and Indonesia suggested
that the 1997 economic crash had a significant impact on
spending by households on health care [21,22]. These
studies reinforce the need for public health action to help
ensure a safety net for the poorest who are most vulner-
able to such shocks.
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bly arise from the data, both in scope and quality. Inter-
pretation of long time series of mortality and birth data
- o v e r7 0y e a r sf o rs o m ec o u n t r i e s-m u s ta c k n o w l e d g e
the risk of artefact effects owing to changing definitions
and completeness and quality of data capture, problems
which are further compounded by cross-country and
pooled analyses. We have endeavoured to limit some of
these risks by excluding data for the early years of the
20
th century which exhibit inconsistencies and implausi-
ble fluctuations. Finally, the processes and factors that
affect maternal and infant health are likely to be differ-
ent from those affecting other measures of health status.
The results may not, therefore, be general to the health
of other population sub-groups.
Conclusions
The historical evidence presented in this paper yields
conclusions that are necessarily speculative, but never-
theless suggest that health gains, particularly in coun-
tries at an early stage of development, are vulnerable to
fluctuating GDP. Substantial additional maternal and
infant deaths can be expected if the associations noted
here for richer countries during the 20
th century are
repeated for countries at similar stages of development
today, particularly as many of these countries have con-
siderably larger populations and much higher levels of
mortality. The challenge for today’s policy makers is the
design and implementation of mechanisms that protect
vulnerable populations from the effects of fluctuating
national income [23]. Financing such systems is out of
the reach of many developing countries using domestic
resources alone and reinforces the need to maintain and
even increase external development assistance during
periods of economic crisis. Such assistance should be
focused on improving systems rather than on traditional
disease specific programme support. It is notable that
health systems in richer countries, including most of the
countries described in this paper, developed both the
readiness to provide service when required and in the
risk pooling function that ensures that financial barriers
do not inhibit use of services. Most health programmes
depend on a common system structure and recognising
these inter-relationships is increasingly seen as an
important part of a development assistance strategy [3].
These inter-relationships are well illustrated in the pro-
vision of maternal health services where well qualified
staff must be supported by a strong infrastructure cap-
able, for example, of ensuring referral, surgical delivery
and a quality blood supply. This suggests that external
assistance to support countries through recession and
help them achieve goals such as the MDGs should be
directed towards two main areas. Firstly, to strengthen
systems for helping individuals and households cope
with both supply and demand side costs of maternal
care [24]. Secondly to assist countries to strengthen sup-
ply-side networks for supporting improved maternal
health services and ensure that services are available
when women present for service.
The current global challenge brought about by finan-
cial collapse comes at a time when progress towards
achieving the MDGs requires speeding-up and scaling-
up. The key question is whether the challenge can cata-
lyse the invariably difficult decision of rationing scarce
resources - here to protect mothers and infants.
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